Cigna Arm To Offer Humira Biosimilar At $0 Cost-Share
Finally, we are making some advances on biosimilar adoption. For awhile, pharmacy benefits managers (PBMs) were teaming up with brand drug makers to stop the uptake of biosimilars through rebate arrangements. That still happens, but PBMs are seeing the light. Evernorth’s Accredo Specialty Pharmacy will make a Humira biosimilar available to patients with no cost-share. Evernorth is partnering to produce the biosimilar. The biosimilar price is about 85% lower than that of the brand.
#biosimilars #drugpricing #brandrugmakers #cigna #evernorth
https://www.fiercehealthcare.com/payers/evernorths-accredo-offer-humira-biosimilar-0-out-pocket
